↓ Skip to main content

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Investigational New Drugs, August 2005
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#43 of 308)
  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
3 Mendeley
Title
Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial
Published in
Investigational New Drugs, August 2005
DOI 10.1007/s10637-005-3536-2
Pubmed ID
Authors

Sanjay Singh Negi, Anil Agarwal, Adarsh Chaudhary

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 33%
Student > Doctoral Student 1 33%
Researcher 1 33%
Readers by discipline Count As %
Unspecified 1 33%
Agricultural and Biological Sciences 1 33%
Medicine and Dentistry 1 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2016.
All research outputs
#2,097,853
of 8,223,523 outputs
Outputs from Investigational New Drugs
#43
of 308 outputs
Outputs of similar age
#76,779
of 233,175 outputs
Outputs of similar age from Investigational New Drugs
#2
of 7 outputs
Altmetric has tracked 8,223,523 research outputs across all sources so far. This one has received more attention than most of these and is in the 60th percentile.
So far Altmetric has tracked 308 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,175 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.